9M26: Capex recovers in Q3, while RP5 power determination slips to 2028
11/11/26 -"Another guidance-confirming quarter: adjusted EBITDA was flat at €7.1bn on a restated basis, adjusted net income rose 4%, and FY2026 and FY2030 targets were reiterated in full. The main change is ..."
Pages
68
Language
English
Published on
11/11/26
You may also be interested by these reports :
11/11/26
Hera posted a solid 9M 26, with adjusted EBITDA up 6.9% to €1,036.7m and adjusted net profit up 16.5% to €296.7m. Q3 carried no special items, and ...
11/11/26
RWE posted a strong 9M 26, with adj. EBITDA up 35% yoy to €4.6bn and adj. EPS up 42% to €2.52, c.85% of the FY guidance mid-point. Supply & Trading ...
11/11/26
Another guidance-confirming quarter: adjusted EBITDA was flat at €7.1bn on a restated basis, adjusted net income rose 4%, and FY2026 and FY2030 ...
09/11/26
We have raised our 2026 estimates to reflect a stronger-than-expected 9M26 and the upgraded guidance, now c.€5.4bn of recurring EBITDA and ...